A collection of interesting information

All kinds of articles, videos, news, blogs, documentaries, etc.
We try to keep the information as up to date as possible and with working links.
If you've found interesting information, please submit.

Vaccine | 25 January 2021
Merck drops 2 potential COVID-19 vaccines after poor results in early testing

Merck is pulling the plugs on two potential COVID-19 vaccines following poor results in early-stage studies. The drugmaker said Monday it will focus instead on studying two possible treatments for the virus that also have yet to be approved by regulators. Merck said its potential vaccines were well tolerated by patients, but they generated an inferior immune system response compared with other competitors' new vaccines. The company is focusing its efforts instead on advancing clinical programs and manufacturing for two potential treatment medications for the virus: MK-7110 and MK-4482 (also known as molnupiravir. Molnupiravir is being developed in collaboration with Ridgeback Bio.


Making cryptocurrency accessible to everyone, by offering low transparent fees, all-in-one platform, a wide range of assets and an easy to use platform.
Trade 1000 euro without commission!
Get this welcome bonus through the link below.
Use €1000 bonus